Tech Company Financing Transactions

Taligen Therapeutics Funding Round

Taligen Therapeutics, based in Aurora, raised $10 million in investment from Alta Partners, Clarus and High Country Venture.

Transaction Overview

Announced On
8/23/2010
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors

Alta Partners (Ed Hurwitz)

Clarus (Nick Galakatos)

High Country Venture

Sanderling Ventures (Timothy Mills)

Proceeds Purpose
The company will use the funding to advance its first drug candidate toward initial human studies.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12635 East Montview Blvd 223
Aurora, CO 80045
USA
Email Address
Overview
Taligen's lead technology is directed at inhibiting factor B, an essential component in the amplification of complement activation. Inhibition of factor B down-regulates complement activation, thereby dampening the inflammatory response.
Profile
Taligen Therapeutics LinkedIn Company Profile
Social Media
Taligen Therapeutics Company Twitter Account
Company News
Taligen Therapeutics News
Facebook
Taligen Therapeutics on Facebook
YouTube
Taligen Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Abbie Celniker
  Abbie Celniker LinkedIn Profile  Abbie Celniker Twitter Account  Abbie Celniker News  Abbie Celniker on Facebook
Chief Scientific Officer
Michael Holers
  Michael Holers LinkedIn Profile  Michael Holers Twitter Account  Michael Holers News  Michael Holers on Facebook
President
Woodruff Emlen
  Woodruff Emlen LinkedIn Profile  Woodruff Emlen Twitter Account  Woodruff Emlen News  Woodruff Emlen on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/23/2010: Inkling venture capital transaction
Next: 8/23/2010: Appia venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary